The American Pharmacists Association (APhA) Nuclear Pharmacy Practice Special Interest Group (SIG) is the association home for nuclear pharmacists. The APhA provides a strong voice and regulatory support for nuclear pharmacy practice. All nuclear pharmacists are encouraged to become a member of APhA.
2020-2021 APhA Nuclear SIG Leadership
Coordinator: Dao Le
Coordinator-elect: Akram Hussein
APhA Nuclear Pharmacy SIG Committees
APhA-APPM Nuclear Pharmacy Practice SIG Education Committee
Provide CPE activities to maintain and enhance nuclear pharmacy and molecular imaging competencies. Organize Annual Meeting programming via identification of session moderators and contributed paper reviewers.
APhA-APPM Nuclear Pharmacy Practice SIG Awards/Nominations Committee
Solicit nominations for candidates and hold annual elections for the SIG Co-Chair position. Actively engaging and supporting nominations for APhA-wide and Nuclear SIG-specific awards.
Chair: Nicki Hilliard
Co-Chair: Duann Thistlethwate
APhA-APPM Nuclear Pharmacy Practice SIG Regulatory Affairs Committee
Create and promote a clear identity for our regulatory efforts within APhA. To help shape the regulatory environment and policy using the expertise of members.
APhA-APPM Nuclear Pharmacy Practice SIG Policy & Professional Affairs Committee
Develop position statements on matters that impact the practice of nuclear pharmacy, as appropriate. Develop guides that represent a uniformity of practice standards for nuclear pharmacy practice.
Chair: Karen Hoang
Co-Chair: Richard Green
APhA-APPM Nuclear Pharmacy Practice SIG New Practitioner Committee
Engage students and new practitioners to nuclear pharmacy specialty via newsletters and electronic media. Encourage awareness and involvement through nuclear rotation listings and Board Certification study groups.
Co-Chairs: Megan Unger and Douglas Buhrmester
APhA Annual Meetings
APhA Annual Meetings are a great networking and educational opportunity. Each year 15 hours of ACPE credit is awarded for nuclear pharmacy programming.